BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 843478)

  • 1. The treatment of hirsutism with cyproterone acetate (an anti-androgen).
    Dewhurst CJ; Underhill R; Goldman S; Mansfield M
    Br J Obstet Gynaecol; 1977 Feb; 84(2):119-23. PubMed ID: 843478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of hirsutism with cyproterone acetate].
    Lachinsky N; van Velde JL; Wildschut J
    Ned Tijdschr Geneeskd; 1976 Jan; 120(5):184-8. PubMed ID: 1250451
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analysis of the results of treatment of idiopathic hirsutism and hirsutism in patients with polycystic ovary syndrome with androcur (cyproterone acetate)].
    Baranowska B; Stopińska-Głuszak ; Niewiadomska A; Rozbicka G
    Endokrynol Pol; 1983; 34(4):227-34. PubMed ID: 6228420
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
    Frölich M; Lachinsky N; Moolenaar AJ
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hirsutism.
    Morris DV
    Clin Obstet Gynaecol; 1985 Sep; 12(3):649-74. PubMed ID: 3905161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hirsutism in micropolycystic ovary syndrome with estrogens and sequential prostagen].
    Porcile A; Martínez E
    Rev Chil Obstet Ginecol; 1982; 47(1):8-17. PubMed ID: 6927152
    [No Abstract]   [Full Text] [Related]  

  • 7. Androstanediolglucuronide: a parameter for peripheral androgen activity before and during therapy with cyproterone acetate.
    Ponjee GA; de Rooy HA; Vader HL
    Acta Endocrinol (Copenh); 1991 Apr; 124(4):411-6. PubMed ID: 1827701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-androgenic steroid cyproterone acetate. Clinical pharmacology and therapeutic use in hirsutism and acne].
    van Wayjen RG; van den Ende A
    Ned Tijdschr Geneeskd; 1976 Jan; 120(5):189-95. PubMed ID: 129710
    [No Abstract]   [Full Text] [Related]  

  • 9. Hirsutism.
    Conway GS; Jacobs HS
    BMJ; 1990 Sep; 301(6753):619-20. PubMed ID: 2224213
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hirsutism by the long-term administration of the anti-androgen cyproterone acetate].
    Stárka L; Hampl R
    Cas Lek Cesk; 1988 Jun; 127(25):790-3. PubMed ID: 2970298
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyproterone acetate treatment of females with hyperandrogenism.
    Julesz J; Faredin I; Tóth I; László FA
    Endokrinologie; 1981 Dec; 78(2-3):168-74. PubMed ID: 6460612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects.
    Ruan X; Kubba A; Aguilar A; Mueck AO
    Eur J Contracept Reprod Health Care; 2017 Jun; 22(3):183-190. PubMed ID: 28463030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hirsutism with cyproterone acetate and percutaneous estradiol].
    Rigaud C; Vincens M; Giacomini P; Kuttenn F; Mauvais-Jarvis P
    Presse Med; 1983 Jan; 12(2):73-6. PubMed ID: 6221318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further clinical experience in the treatment of hirsutism with cyproterone acetate.
    Underhill R; Dewhurst J
    Br J Obstet Gynaecol; 1979 Feb; 86(2):139-41. PubMed ID: 427053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cyproterone acetate. 15 cases of hirsutism treated for 1 year].
    Houdent C; Kuhn JM; Balacheff O; Leclerc P; Legrand A; Wolf LM
    Ann Endocrinol (Paris); 1983; 44(6):397-401. PubMed ID: 6234850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiological review of hirsutism in 250 patients.
    Morán C; Tapia MC; Hernández E; Vázquez G; García-Hernández E; Bermúdez JA
    Arch Med Res; 1994; 25(3):311-4. PubMed ID: 7803980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome.
    Bhattacharya SM; Jha A
    Fertil Steril; 2012 Oct; 98(4):1053-9. PubMed ID: 22795636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-androgen treatment of hirsutism with cyproterone acetate].
    Kása M; Egyedi K; Raffai S; Török L
    Z Hautkr; 1990 Dec; 65(12):1112-4. PubMed ID: 2150902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound study of ovarian and uterine morphology in women with polycystic ovary syndrome before, during and after treatment with cyproterone acetate and ethinyloestradiol.
    Venturoli S; Paradisi R; Saviotti E; Porcu E; Fabbri R; Orsini LF; Bovicelli L; Flamigni C
    Arch Gynecol; 1985; 237(1):1-10. PubMed ID: 2932064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hirsutism].
    van Zuuren EJ; Pijl H
    Ned Tijdschr Geneeskd; 2007 Oct; 151(42):2313-8. PubMed ID: 18064932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.